Sihuan Pharmaceutical Gr... (SHPHF)

AI Score

Unlock

0.12

-0.00 (-1.48%)

At close: Apr 23, 2025, 8:00 PM

Sihuan Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q2 2022	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	949.7M	804.83M	1.06B	1.46B	1.91B	1.41B	1.05B	1.22B	1.66B	1.64B	1.28B	1.31B	1.44B	1.8B	1.39B
Cost of Revenue	341.18M	256.92M	307.97M	460.51M	440.1M	281.3M	268.48M	296.9M	292.09M	285.75M	252.56M	337.01M	421.94M	536.5M	460.25M
Gross Profit	608.52M	547.91M	747.73M	1B	1.47B	1.13B	786.06M	923.78M	1.37B	1.35B	1.03B	968.49M	1.02B	1.26B	927.42M
Operating Income	109.1M	15.54M	60.51M	74.66M	751.18M	237.89M	247.92M	357.91M	1.04B	861.55M	862.06M	667.09M	797.92M	1.11B	828.15M
Interest Income	n/a	65.33M	56.09M	25.26M	52.94M	61.89M	65.63M	55.5M	109.5M	88.7M	69.8M	52.9M	44.53M	68.21M	43.11M
Pretax Income	-19.21M	-128.21M	-33.05M	56.04M	819.48M	463.72M	302.12M	-718.05M	-1.7B	1.09B	921.05M	731.89M	997.19M	1.26B	890.47M
Net Income	-33.42M	-4.37M	-49.64M	40.38M	611.42M	333.87M	174.43M	-711.39M	-2B	854.28M	765.67M	606.48M	842.46M	972.27M	735.97M
Selling & General & Admin	453.81M	486.56M	424.65M	549.95M	539.59M	509.9M	348.67M	376.69M	340.26M	386.39M	280.84M	212.71M	340.03M	413.71M	272.52M
Research & Development	195.59M	297.97M	294.04M	457.27M	333.56M	577.84M	300.85M	365.31M	233.65M	300.39M	179.94M	212.03M	91.9M	124.57M	44.8M
Other Expenses	-149.98M	-252.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	499.41M	532.37M	724.69M	922.39M	700.58M	726.55M	549.56M	1.7B	3.18B	350.92M	174.5M	289.5M	65.71M	67.64M	80.06M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	213.47M	229.77M	212.49M	229.64M	260.92M	232.28M	136.51M	127.45M	117.93M	170.15M	100.97M	156.61M	71.03M	89.9M	55.86M
Cost & Expenses	840.59M	789.3M	1.03B	1.38B	1.14B	1.01B	818.04M	1.99B	3.47B	636.68M	427.06M	626.51M	487.65M	604.14M	540.31M
Income Tax Expense	48.75M	10.54M	85.89M	151.94M	225.26M	85.61M	133.43M	53.17M	237.22M	197.99M	134.82M	93.45M	156.72M	300.22M	172.52M
Shares Outstanding (Basic)	9.28B	8.91B	9.31B	9.39B	9.52B	9.47B	9.49B	9.47B	9.47B	9.47B	9.47B	9.47B	9.49B	9.92B	10.36B
Shares Outstanding (Diluted)	9.28B	9.28B	9.31B	9.33B	9.52B	9.47B	9.47B	9.47B	9.47B	9.47B	9.47B	9.47B	9.49B	9.92B	10.36B
EPS (Basic)	-0.00	-0.00	-0.01	0.00	0.06	0.04	0.02	-0.08	-0.21	0.09	0.08	0.06	0.09	0.10	0.07
EPS (Diluted)	-0.00	-0.00	-0.01	0.00	0.06	0.04	0.02	-0.08	-0.21	0.09	0.08	0.06	0.09	0.10	0.07
EBITDA	113.83M	-128.71M	168.92M	237.95M	893.9M	337.06M	377M	430.15M	1.2B	914.08M	1B	734.52M	944.93M	1.22B	964.12M
EBIT	4.65M	-201.05M	60.51M	74.66M	751.18M	237.89M	247.92M	357.91M	1.04B	861.55M	862.06M	667.09M	797.92M	1.11B	828.15M
Depreciation & Amortization	109.18M	72.34M	108.42M	163.29M	142.72M	99.17M	129.07M	72.25M	162.23M	52.54M	141.09M	67.43M	147.01M	109.93M	135.98M